Updated Jul 16, 2026
Von Koch Thomas is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $10.00M.
Thomas Von Koch is a corporate insider and a 10% owner of DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing treatments for ischemic diseases. His involvement in the company is primarily as a significant shareholder.
| Role | 10% Owner |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-23 | DMAC | DiaMedica Therapeutics Inc. | P — Open-market purchase | 2.86M | $3.50 | $10.00M |
Thomas Von Koch is a corporate insider and a 10% owner of DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing treatments for ischemic diseases. His involvement in the company is primarily as a significant shareholder.…
Recorded transactions: 1 open-market purchases ($10.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Von Koch Thomas profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.